BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/10/2025 7:54:05 AM | Browse: 34 | Download: 101
Publication Name World Journal of Gastroenterology
Manuscript ID 111631
Country China
Received
2025-07-07 08:14
Peer-Review Started
2025-07-07 08:14
First Decision by Editorial Office Director
2025-08-11 07:30
Return for Revision
2025-08-11 07:30
Revised
2025-09-21 09:56
Publication Fee Transferred
Second Decision by Editor
2025-10-24 02:39
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-10-24 06:40
Articles in Press
2025-10-24 06:40
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-12-04 07:46
Publish the Manuscript Online
2025-12-10 07:48
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression
Manuscript Source Unsolicited Manuscript
All Author List Yi Si, Bo Tian, Rui Zhang, Ming-Da Xuan, Kun-Yi Liu, Jiao Jiao, Shuang-Shuang Han, Hong-Fei Li, Yan-Hong Hu, Hong-Yan Zhao, Wen-Jing He, Jia Wang, Ting Liu and Wei-Fang Yu
Funding Agency and Grant Number
Funding Agency Grant Number
Hebei Natural Science Foundation No. H2025206524
Hebei Natural Science Foundation No. H2022206292
Hebei Natural Science Foundation No. H2024206140
Hebei Provincial Government-funded Provincial Medical Excellent Talent Project No. ZF2023025
Hebei Provincial Government-funded Provincial Medical Excellent Talent Project No. ZF2024134
Hebei Provincial Government-funded Provincial Medical Excellent Talent Project No. LS202008
Key RD Program of Hebei Province No. 223777103D
Key RD Program of Hebei Province No. 223777113D
Prevention and Treatment of Geriatric Diseases by Hebei Provincial Department of Finance No. LNB202202
Prevention and Treatment of Geriatric Diseases by Hebei Provincial Department of Finance No. LNB201909
Spark Scientific Research Project of the First Hospital of Hebei Medical University No. XH202504
Spark Scientific Research Project of the First Hospital of Hebei Medical University No. XH202312
Spark Scientific Research Project of the First Hospital of Hebei Medical University No. XH201805
Hebei Province Medical Applicable Technology Tracking Project No. G2019035
Corresponding Author Wei-Fang Yu, Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang 050000, Hebei Province, China. yuweifang@hebmu.edu.cn
Key Words Gastric cancer; N6-methyladenosine; IGF2BP3; FBXO32; Cyclic guanosine monophosphate-protein kinase G
Core Tip IGF2BP3 is highly expressed in gastric cancer and is closely associated with poor patient prognosis. IGF2BP3 promotes gastric cancer growth and progression both in vivo and in vitro. Mechanistically, IGF2BP3 recognizes and binds to N6-methyladenosine-modified site on FBXO32 messenger RNA, thereby upregulating FBXO32 protein expression. This activates the downstream cyclic guanosine monophosphate-protein kinase G (cGMP-PKG) signaling pathway, thereby regulating multiple biological functions of gastric cancer cells and promoting tumor progression. We propose that targeting of the IGF2BP3/FBXO32/cGMP-PKG axis could represent a promising therapeutic modality for gastric cancer.
Publish Date 2025-12-10 07:48
Citation

Si Y, Tian B, Zhang R, Xuan MD, Liu KY, Jiao J, Han SS, Li HF, Hu YH, Zhao HY, He WJ, Wang J, Liu T, Yu WF. IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression. World J Gastroenterol 2025; 31(46): 111631

URL https://www.wjgnet.com/1007-9327/full/v31/i46/111631.htm
DOI https://dx.doi.org/10.3748/wjg.v31.i46.111631
Full Article (PDF) WJG-31-111631-with-cover.pdf
The ARRIVE Guidelines 111631-The-ARRIVE-Guidelines.pdf
Manuscript File 111631_Auto_Edited_045935.docx
Answering Reviewers 111631-answering-reviewers.pdf
Audio Core Tip 111631-audio.m4a
Biostatistics Review Certificate 111631-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 111631-conflict-of-interest-statement.pdf
Copyright License Agreement 111631-copyright-assignment.pdf
Institutional Animal Care and Use Committee Approval Form or Document 111631-institutional-animal-care-and-use-committee-statement.pdf
Institutional Review Board Approval Form or Document 111631-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 111631-non-native-speakers.pdf
Supplementary Material 111631-supplementary-material.pdf
Peer-review Report 111631-peer-reviews.pdf
Scientific Misconduct Check 111631-scientific-misconduct-check.png
Scientific Editor Work List 111631-scientific-editor-work-list.pdf
CrossCheck Report 111631-crosscheck-report.pdf